Jitai Technology's AI Formulation Platform to Be Deployed at Hengrui Medicine
Jitai Technology announced on the Hong Kong Stock Exchange that its self-developed AiTEM artificial intelligence formulation innovation platform will be locally deployed at Jiangsu Hengrui Medicine Co. , Ltd. to accelerate the efficiency of drug formulation development. The collaboration between the two parties focuses on the field of AI formulation platform, with the aim of enhancing the level of automation and intelligence in the drug research and development process through technology deployment.
Why this event matters
The event has a measured impact on 2 industrys. The strongest current signal is positive for Pharmaceutical R&D Services, with intensity 40/100 and 70% confidence over a medium term horizon.
Pharmaceutical R&D Services
- Direction
- positive
- Intensity
- 40
- Confidence
- 70%
- Horizon
- Medium term
Artificial Intelligence
- Direction
- positive
- Intensity
- 30
- Confidence
- 60%
- Horizon
- Medium term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.